Results 21 to 30 of about 75,961 (168)

Trends in extent of surgical cytoreduction for patients with ovarian cancer.

PLoS ONE, 2021
PurposeTo identify patient and hospital characteristics associated with extended surgical cytoreduction in the treatment of ovarian cancer.MethodsA retrospective analysis using the National Inpatient Sample (NIS) database identified women hospitalized ...
Deanna H Wong, Alexandra L Mardock, Erica N Manrriquez, Tiffany S Lai, Yas Sanaiha, Abdulrahman K Sinno, Peyman Benharash, Joshua G Cohen   +7 more
doaj   +3 more sources

Evaluation of the relationship between lactacidemia and postoperative complications after surgery for peritoneal carcinomatosis [PDF]

Korean Journal of Anesthesiology, 2021
Background Cytoreductive surgery was developed as a treatment for peritoneal carcinomatosis. However, this surgery is associated with important complications.
Marta Soriano Hervás, Rosa Játiva-Porcar, Daniel Robles-Hernández, Anna Serra Rubert, Blanca Segarra, Cristina Oliva, Javier Escrig, José Antonio Llueca   +7 more
doaj   +1 more source

Survival Impact of Secondary Cytoreductive Surgery for Recurrent Ovarian Cancer in an Asian Population

Oman Medical Journal, 2015
Objective: The aim of this study was to evaluate the role of secondary cytoreductive surgery in Asian patients with recurrent ovarian cancer and to assess prognostic variables on overall post-recurrence survival time.
Rani Akhil Bhat, Yin Nin Chia, Yong Kuei Lim, Kwai Lam Yam, Cindy Lim, Melissa Teo   +5 more
doaj   +1 more source

A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy

BMC Cancer, 2017
Background This study aimed to evaluate the perioperative outcomes and prognostic impact of the consecutive steps of imaging, frailty assessment, and diagnostic laparoscopy (DLS) in patients with advanced epithelial ovarian cancer (EOC). Methods Patients
Kyung Jin Eoh, Jung Won Yoon, Jung-Yun Lee, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim   +6 more
doaj   +1 more source

Preliminary Experience and Morbidity Analysis of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/Hipec) from a Tertiary Cancer Center in India [PDF]

Journal of Clinical and Diagnostic Research, 2015
Background: Peritoneal carcinomatosis (PC) can arise directly from peritoneum (primary) or from regional spread of gastrointestinal and gynecological malignancies. It is often considered a terminal event.
Naveen Padmanabhan, Barath Raj Kumar, Ansar Pullampara Pookunju, Ayyapan Srinivasan, Vikash Mahajan   +4 more
doaj   +1 more source

Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)

Pleura and Peritoneum, 2023
There are limited treatment options and no consensus on the management of advanced rare ovarian malignancies. Rare ovarian malignancies can present with peritoneal metastases (PM), featuring a similar presentation to more common ovarian subtypes ...
Falla-Zuniga Luis Felipe, Sardi Armando, King Mary Caitlin, Lopez-Ramirez Felipe, Barakat Philipp, Nieroda Carol, Diaz-Montes Teresa, Gushchin Vadim   +7 more
doaj   +1 more source

Unsupervised identification of surgical robotic actions from small non homogeneous datasets [PDF]

IEEE Robotics and Automation Letters, vol.6, issue 4, October 2021, 2021
Robot-assisted surgery is an established clinical practice. The automatic identification of surgical actions is needed for a range of applications, including performance assessment of trainees and surgical process modeling for autonomous execution and monitoring.
arxiv   +1 more source

Perioperative management of cytoreductive surgery and hyperthermic intraoperative thoraco-abdominal chemotherapy (HITAC) for pseudomyxoma peritonei

Indian Journal of Anaesthesia, 2019
Peritoneal carcinomatosis is intraperitoneal spread of gastrointestinal and gynaecological cancers. Cytoreductive surgeries and hyperthermic intraperitoneal chemotherapy offers survival benefits in these cases.
Sohan Lal Solanki, Jhanvi S Bajaj, Febin Rahman, Avanish P Saklani   +3 more
doaj   +1 more source

Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)

Indian Journal of Anaesthesia, 2019
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for primary peritoneal malignancies or peritoneal spread of malignant neoplasm is being done at many centres worldwide.
Sohan Lal Solanki, Sudipta Mukherjee, Vandana Agarwal, Raghu S Thota, Kalpana Balakrishnan, Shagun Bhatia Shah, Neha Desai, Rakesh Garg, Reshma P Ambulkar, Nitin Madhukar Bhorkar, Viplab Patro, Snita Sinukumar, Meenakshi V Venketeswaran, Malini P Joshi, Rajesh Holalu Chikkalingegowda, Vijaya Gottumukkala, Pascal Owusu-Agyemang, Avanish P Saklani, Sanket Sharad Mehta, Ramakrishnan Ayloor Seshadri, John C Bell, Sushma Bhatnagar, Jigeeshu V Divatia   +22 more
doaj   +1 more source

Does the Performance of Splenectomy as Part of Cytoreductive Surgery Carry a Worse Prognosis Than in Patients Not Receiving Splenectomy? A Propensity Score Analysis and Review of the Literature

Journal of Investigative Surgery, 2022
Background & Objectives Ultra-radical (UR) procedures, including splenectomy, are utilized to increase complete cytoreduction rates during Cytoreductive Surgery (CRS) performed with the aim of complete macroscopic clearance of disease.
James Davies, Viren Asher, Anish Bali, Summi Abdul, Andrew Phillips   +4 more
doaj   +1 more source